Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangelos Giannitsis

Showing results (1-10 of 430) with videos related to

Pageof 43
Sort By:
Clinical Laboratory|February 22, 2005
Rationale for testing the cardiovascular risk for patients with COX-2 inhibitors on the basis of biomarker NT-proBNPEvangelos Giannitsis
Clinical Chemistry|November 30, 2016
Counterpoint: Potential Concerns Regarding the Use of Sex-Specific Cutpoints for High-Sensitivity Troponin AssaysEvangelos Giannitsis
Heart (British Cardiac Society)|January 6, 2016
Sex-specific troponin measures for diagnosis of acute coronary syndromeEvangelos Giannitsis
Deutsche Medizinische Wochenschrift (1946)|June 4, 2020
[Cardiac biomarkers and COVID-19 - Phenotypes and Interpretation]Christian Salbach, Evangelos Giannitsis
Herz|May 30, 2020
Biomarkers for infarct diagnosis and rapid rule-out/rule-in of acute myocardial infarctionEvangelos Giannitsis, Vinayak Gopi
European Heart Journal|February 17, 2022
Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at bestEvangelos Giannitsis, Norbert Frey
Current Atherosclerosis Reports|January 16, 2014
"Troponin elevation in coronary ischemia and necrosis"Stefan Agewall, Evangelos Giannitsis
Critical Care Medicine|October 21, 2006
Risk stratification in patients with confirmed pulmonary embolism: what to do when echocardiography is not availableEvangelos Giannitsis, Hugo A Katus
Clinical Chemistry|June 25, 2017
Prognostic Value of Serum Troponin T in Unstable AnginaHugo A Katus, Evangelos Giannitsis
Critical Care Medicine|November 8, 2003
Still unresolved issues with brain-type natriuretic peptide measurement in the critically ill patientEvangelos Giannitsis, Hugo A Katus
Pageof 43

Showing results (1-10 of 430) with videos related to

Sort By:
Pageof 43
Clinical Laboratory|February 22, 2005
Rationale for testing the cardiovascular risk for patients with COX-2 inhibitors on the basis of biomarker NT-proBNPEvangelos Giannitsis
Clinical Chemistry|November 30, 2016
Counterpoint: Potential Concerns Regarding the Use of Sex-Specific Cutpoints for High-Sensitivity Troponin AssaysEvangelos Giannitsis
Heart (British Cardiac Society)|January 6, 2016
Sex-specific troponin measures for diagnosis of acute coronary syndromeEvangelos Giannitsis
Deutsche Medizinische Wochenschrift (1946)|June 4, 2020
[Cardiac biomarkers and COVID-19 - Phenotypes and Interpretation]Christian Salbach, Evangelos Giannitsis
Herz|May 30, 2020
Biomarkers for infarct diagnosis and rapid rule-out/rule-in of acute myocardial infarctionEvangelos Giannitsis, Vinayak Gopi
European Heart Journal|February 17, 2022
Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at bestEvangelos Giannitsis, Norbert Frey
Current Atherosclerosis Reports|January 16, 2014
"Troponin elevation in coronary ischemia and necrosis"Stefan Agewall, Evangelos Giannitsis
Critical Care Medicine|October 21, 2006
Risk stratification in patients with confirmed pulmonary embolism: what to do when echocardiography is not availableEvangelos Giannitsis, Hugo A Katus
Clinical Chemistry|June 25, 2017
Prognostic Value of Serum Troponin T in Unstable AnginaHugo A Katus, Evangelos Giannitsis
Critical Care Medicine|November 8, 2003
Still unresolved issues with brain-type natriuretic peptide measurement in the critically ill patientEvangelos Giannitsis, Hugo A Katus
Pageof 43